WHO ICTRP trial
Clinical research and treatment strategy exploration of high risk factors and M0…
ChiCTR2000035394 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000035394 |
|---|---|
| Public title | Clinical research and treatment strategy exploration of high risk factors and M0 (I +) staging diagnostic criteria of renal cell carcinoma guided by circulating tumor cell typing and related markers detection |
| Scientific title | Research on detection of circulating tumor cells and circulating tumor cells - white blood cells to guide the development of standardization of renal cancer Mi (cytological metastasis) and clinical evaluation of renal cancer prognosis |
| Primary sponsor | The Second Affiliated Hospital of Xi'an Jiaotong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Kidney Cancer |
| Interventions | Case series:Nil |
| Registration date | Aug 10, 2020 |
| Target size | Case series:500 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: